Notably, most of the cancer types that showed higher irAE ROR than predicted by the combined PD-L1 protein expression and fPD1 model had higher DHX16 expression abundances, whereas those showing lower than bivariate model-based predicted irAE risk had lower DHX16 expression levels (Figure 1C). The gene discussed is DHX16; the disease is cancer.